HGWM
LAB icon

Harvest Group Wealth Management’s Standard BioTools LAB Stock Holding History

Harvest Group Wealth Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$283 Hold
145
– – ﹤0.01% 175
2022
Q4 		$170 Hold
145
– – ﹤0.01% 182
2022
Q3 		$0 Hold
145
– – ﹤0.01% 189
2022
Q2 		$0 Buy
+145
New +$359 ﹤0.01% 204

Other funds holding LAB

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
ICM
Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Harvest Group Wealth Management's LAB Position: Q1 2023 in Review

Harvest Group Wealth Management held its Standard BioTools (LAB) position steady in Q1 2023 at 145 shares worth $283. The position accounts for ﹤0.01% of the portfolio, ranked #175.

Harvest Group Wealth Management first reported a position in LAB in Q2 2022 and has held it in 4 quarters since. 69 funds tracked by Wall St. Rank hold LAB as of Q1 2023.

  • Harvest Group Wealth Management held 145 shares of Standard BioTools worth $283 as of Q1 2023.
  • Harvest Group Wealth Management left its Standard BioTools share count unchanged in Q1 2023.
  • Standard BioTools made up ﹤0.01% of Harvest Group Wealth Management's portfolio in Q1 2023, its #175 holding.
  • Harvest Group Wealth Management first reported a position in Standard BioTools in Q2 2022 and has held it in 4 quarters since.
  • 69 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2023.

Based on Harvest Group Wealth Management's 13F filing for Q1 2023, filed 28 Apr 2023.